Generics 124

Originals 2

Biosimilars

Medical devices

Nutraceuticals 1

Filters

Ursodeoxycholic acid manufacturers

124 products found

Filters

124 products found

ursodeoxycholic acid

Capsules 250mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Australia , Azerbaijan , Bahrain , Belgium , Chile , Czech Republic , Denmark , Estonia , Finland , Kazakhstan , Kuwait , Latvia , Lithuania , Netherlands , New Zealand , Norway , Oman , Poland , Portugal , Qatar , Saudi Arabia , Singapore , Sweden , United Arab Emirates , United Kingdom , Vietnam
Available for
Distribution only
Manufacturer #1250

Manufacturer usually replies in 4 days

ursodeoxycholic acid

Capsules 150 mg, 300 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Honduras , Nicaragua , Panama
Manufacturer #17633
In the 1950s, the pharmaceutical laboratory was established. Its first manufacturing facility for inhalation aerosols was established in the 1960s, making it one of the first companies to introduce such a product to the market. It was one of the first firms in the world to sell silver sulfadiazine as a pharmaceutical product in cream and aerosol form.

Manufacturer usually replies in 8 days

ursodeoxycholic acid

Tablets, prolonged release (PR) 450 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Technology transfer
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

Want to see all 124 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules. The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks. Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation